editorials · reviews · multicenter studies · meta-analyses · randomized controlled trials · retractions
Med Lett Drugs Ther · Aug 2005
A selective serotonin and norepinephrine reuptake inhibitor approved for depression and now also for diabetic peripheral neuropathy.
read on… or not…
We guarantee your privacy. Your email address will not be shared.
Receive a weekly email with the highest quality and most significant abstracts from critical care specialties.
Anesthesiology, Critical Care Medicine, Emergency Medicine, Medicine, and Pain medicine.
Includes a free 21 day trial of metajournal premium
We guarantee your privacy. Your email address will not be shared. Unsubscribe anytime.